Peripheral Leukocyte Apoptosis in Patients with Parkinsonism: Correlation with Clinical Characteristics and Neuroimaging Findings
Author(s) -
Wei-Che Lin,
NaiWen Tsai,
YungCheng Huang,
KueiYueh Cheng,
Hsiu-Ling Chen,
Shau-Hsuan Li,
ChiaTe Kung,
YuJih Su,
Wei-Ming Lin,
MengHsiang Chen,
Tsui-Min Chiu,
I-Hsiao Yang,
ChengHsien Lu
Publication year - 2014
Publication title -
biomed research international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 126
eISSN - 2314-6141
pISSN - 2314-6133
DOI - 10.1155/2014/635923
Subject(s) - neurodegeneration , parkinsonism , parkinson's disease , biomarker , disease , medicine , dopamine transporter , apoptosis , pathophysiology , peripheral , dopamine , inflammation , neuroscience , neuroimaging , immunology , pathology , oncology , bioinformatics , biology , dopaminergic , psychiatry , biochemistry
Apoptosis of both brain neurons and peripheral blood leukocyte is believed to be an important biomarker for evaluating the functional status of Parkinson's disease (PD). However, their correlation remains unknown. A better understanding of the pathophysiology of neurodegeneration is essential for the treatment and prevention of PD. The present study demonstrated that leukocyte apoptosis is significantly higher in PD patients and is associated with central dopamine neuron loss by using 99m Tc-TRODAT-1 SPECT. The leukocyte apoptosis and striatal dopamine transporter uptake ratios were further associated with increased severity and longer duration of disease. The interaction between brain and systemic inflammation may be responsible for the neurodegenerative disease progression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom